Navigation Links
IFT session looks at changes in dietary fat and heart disease paradigm
Date:5/24/2010

involved in establishing the dietary fat and fatty acid recommendations, and new research on effects of diet on risk factors for coronary heart disease that may impact future recommendations.

  • Mark Pereira, Ph.D., associate professor, Division of Epidemiology & Community Health, University of Minnesota. Dr. Pereira will present the epidemiological research on influence of diet on atherosclerosis progression, looking at specific nutrients such as carbohydrate, total fat, and saturated, monounsaturated and polyunsaturated fats. Evidence will be presented indicating the diet-heart paradigm is modified by dietary components including omega-3 fatty acids, trans fatty acids, types of carbohydrates and food including nuts, legumes, dairy products, fruits and vegetables. He will also review the new World Health Organization/Food and Agriculture Organization dietary fat recommendations.

  • Roger Clemens, Ph.D., associate director, Regulatory Science Program, School of Pharmacy, University of Southern California. Dr. Clemens' presentation will focus on application of the changing dietary fat-heart disease paradigm to the food industry. After years of providing the consumer low-fat and non-fat products to reduce risk of heart disease, how should food manufacturers respond to the changing nutritional environment around dietary fats?

    Cindy Schweitzer, Ph.D., technical director, Global Dairy Platform, will moderate the session which will take place on Monday, July 19 from 1:30 to 3 p.m. in room S403ab in the Chicago Convention Center.


    '/>"/>


  • Contact: Jessica Northrup
    jn@nstpr.com
    619-302-0833
    Dairy Council of California
    Source:Eurekalert

    Page: 1 2

    Related biology news :

    1. Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10
    2. USC researchers present diabetes findings at American Diabetes Association Scientific Sessions
    3. BIO 2009 -- R&D session: New stem cell research unlocks unknown therapies
    4. Meet-the-expert sessions on 20 key topics to enhance scientific programme of IOFWCO-ECCEO10
    5. Toxicology program features wide range of human health and environment topical sessions
    6. Nutrition and bone health session to open the IOF World Congress on Osteoporosis in Bangkok
    7. For insulin sensitive overweight patients, 1 session of exercise improves metabolic health
    8. Study looks at gorillas, elephants and logging in Congo
    9. Educational historian looks at origins of the culture wars
    10. City of Winter Park Looks to DigitalPersona Software for Stronger Security and CJIS Compliance
    11. It looks, feels and tastes like chicken, but its made of soy
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... Inc. , a market leader of iris-based identity authentication solutions, ... the new role of Senior Vice President of Mobile and ... platforms and wearable solutions for EyeLock,s technologies. Gerber brings more ... industry to his role at EyeLock, with expertise in human ...
    (Date:12/22/2014)... 2014 Holiday Season may be the brightest ever for ... the long anticipated floodgates for consumer biometrics may finally ... phones, tablets, and wearable mobile devices that incorporate biometrics ... with nearly 4.8 billion biometric devices by 2020.   ...
    (Date:12/17/2014)... DUBLIN , Dec. 15, 2014 Research and Markets ... of the "Samsung Galaxy S5 - Home Button ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... the iPhone 5S, Samsung introduces for the first time ...
    Breaking Biology News(10 mins):EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
    ... multiple sclerosis (MS), neuroradiologists and neurologists of the University ... visualize inflammatory tissue damage, most of which had remained ... new contrast medium, Gadofluorine M, in magnetic resonance imaging. ... edition of the renowned medical journal Brain . ...
    ... About 4,000 children in the United States die every ... septic shock, and researchers are pushing the boundaries of ... the condition. But a simple measure of an immune ... the hospital for septic shock can predict survival in ...
    ... a pilot study in children with sarcoma, researchers at ... could prove beneficial in treating high-risk forms of this ... vaccine as well as a standard flu vaccine to ... findings, published in the August 1 issue of ...
    Cached Biology News:Multiple Sclerosis: new MRI contrast medium enables early diagnosis in animal model 2Immune system protein accurate predictor of survival in pediatric septic shock 2Immune system protein accurate predictor of survival in pediatric septic shock 3Immunotherapy in high-risk pediatric sarcomas shows promising response 2Immunotherapy in high-risk pediatric sarcomas shows promising response 3
    (Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval ... for the use of Medtronic,s SynchroMed ® II ... for use with United Therapeutics, Remodulin ® (treprostinil) ...
    (Date:12/24/2014)... Texas , Dec. 24, 2014  Vermillion, Inc. ... on gynecologic disease, announced today that the Company ... including Oracle Investment Management, Jack W. Schuler ... Total proceeds were $10.5 million, before offering expenses.  ...
    (Date:12/24/2014)... (PRWEB) December 23, 2014 “Preparative ... Gas, HPLC, Flash), Consumables (Columns, Solvents, Buffers, Valves, ... Food & Agriculture) - Forecasts to 2019” provides ... challenges, opportunities, current market trends, and strategies impacting ...
    (Date:12/24/2014)... MA (PRWEB) December 23, 2014 Earlier this ... L. Sherley, director of the Adult Stem Cell Technology Center, ... and under appreciated unique property of adult tissue stem cells. ... in the Past, Important for the Future,” embodied the essence ...
    Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
    ... the Sale of Ready to Drink,Suite of Nutritional Supplements to Provider ... ... BASKING RIDGE, N.J., June 5 Millennium Biotechnologies,Inc., wholly owned subsidiary ... it has entered into an,amendment of it,s November 9th 2007 Master ...
    ... Compendia Bioscience today,announced that it has signed ... GSK ) for Oncomine(TM) Enterprise Edition, a,value-added ... Edition builds upon the features of Oncomine,Professional ... to securely,view proprietary gene expression data in ...
    ... LAWRENCE, Mass., June 5 NxStage Medical, Inc.,(Nasdaq: ... announced that Jeffrey H. Burbank, Chief Executive Officer, and,Robert ... the William,Blair 28th Annual Growth Stock Conference on June ... NxStage,s investor presentation is scheduled for Wednesday, June ...
    Cached Biology Technology:Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc. 2Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc. 3GlaxoSmithKline Signs Licensing Agreement With Compendia Bioscience 2NxStage Medical to Present at William Blair Growth Stock Conference 2
    ... are cytopathic effect inhibition assays, also known as ... tissue culture supernatents; serum from PK studies and ... is defined as the quantity of interferon required ... viral infection by 50%. All standards ...
    ... cytopathic effect inhibition assays, also known as CPE ... culture supernatents; serum from PK studies and delivery ... defined as the quantity of interferon required per ... infection by 50%. All standards used ...
    Request Info...
    Request Info...
    Biology Products: